Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples



► Subscribe to EMAT database


Sectors covered by our analysts


► Studies & indices published by Epsilon Research: Register to receive (free) publications updates


► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Transaction Multiples for the Valuation of Private Companies

Koninklijke DSM / Adare Pharmaceuticals (Adare Biome)

No EMAT : 112493
Announced Date : 19/04/2023
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Koninklijke DSM

Target : Adare Pharmaceuticals (Adare Biome)
Country : Yvelines
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Adare Pharmaceuticals SAS (Adare Biome) develops, produces, and commercializes postbiotic solutions , including its pharmaceutical product Lactéol™ marketed in almost 40 countries around the world,...

Transaction multiples available
Gross Profit
P/E Price
to Book
Historic ns
Rating : ***
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
28/09/2020 Series A fund raising by Greycroft and Bullpen Capital Sempiternal Aesthetics (SISU Aesthetic Clinic) Ireland * 112405
27/06/2019 Dermedis Clinique Matignon Suisse Switzerland * 112356

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report